RenovoRx (RNXT) Financials: Revenue & Earnings
RNXT$1.43+0.04 +2.88%
$64.54M
Market Cap
-4.08
P/E
39.00
Forward P/E
—
Score
RenovoRx (RNXT) Financials: Revenue & Earnings
RNXT price $1.43 +0.04 +2.88%
- Ticker
- RNXT
- Price
- $1.43
- Change
- +0.04 +2.88%
- Market cap ?
- $64.54M
- P/E ?
- -4.08
- Forward P/E ?
- 39.00
- Dividend yield ?
- 0.00%
- Beta ?
- 0.97
- Sector
- Healthcare
- Industry
- Biotechnology
Financials
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 43000 | 1123000 |
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer…
Fair value
RNXT fair value $0.90. Price $1.43. Price is 59% above fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 247.15K. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.66% (beta 1.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 45.13M. Net debt -6.81M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -0.05 | — | 1.06M |
| 2026-08-12 | -0.05 | -0.07 | 909.00K | 703.75K |
| 2026-05-14 | -0.08 | -0.08 | 563.00K | 469.50K |
| 2026-03-30 | -0.08 | -0.08 | 238.00K | 419.70K |
| 2025-11-13 | -0.08 | -0.08 | 266.00K | 405.40K |
| 2025-08-14 | -0.08 | -0.08 | 422.00K | 304.00K |
| 2025-05-15 | -0.08 | -0.08 | 197.00K | 183.33K |
| 2025-03-31 | -0.12 | -0.13 | 43.00K | 167.50K |
| 2024-11-13 | -0.10 | -0.12 | — | — |
| 2024-08-13 | -0.10 | -0.10 | — | — |
| 2024-05-10 | -0.07 | -0.14 | — | — |
| 2024-04-02 | -0.31 | -0.30 | — | — |
| 2023-11-14 | -0.13 | -0.30 | — | — |
| 2023-08-16 | -0.22 | -0.25 | — | — |
| 2023-05-15 | -0.36 | -0.25 | — | — |
| 2023-03-02 | -0.23 | -0.26 | — | — |
| 2022-11-14 | -0.24 | -0.27 | — | — |
| 2022-08-15 | -0.29 | -0.28 | — | — |
| 2022-05-16 | -0.33 | -0.25 | — | — |
| 2022-03-30 | -0.12 | -0.16 | — | — |
| 2021-11-15 | -0.27 | -0.21 | — | — |
| 2021-08-27 | -0.08 | — | — | — |
| 2021-03-31 | -0.07 | — | — | — |
| 2020-12-31 | -0.05 | — | — | — |
| 2020-09-30 | -0.07 | — | — | — |
| 2020-06-30 | -0.05 | — | — | — |
| 2020-03-31 | -0.09 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Macfarlane K. Angela | Buy | 55.92K | $1.55 | 86.68K |
| 2026-10-01 | Spiegel Robert J. | Buy | 55.92K | $1.55 | 86.68K |
| 2026-10-01 | RYAN UNA S | Buy | 55.92K | $1.55 | 86.68K |
| 2026-10-01 | Marton Laurence | Buy | 55.92K | $1.55 | 86.68K |
| 2026-09-10 | VOLL MARK | Buy | 80.00K | — | — |
| 2026-05-19 | VOLL MARK | Buy | 25.00K | $0.79 | 19.69K |
| 2026-04-03 | Bagai Shaun | Buy | 946.11K | $0.98 | 927.18K |
| 2026-04-03 | VOLL MARK | Buy | 80.00K | — | — |
| 2026-04-03 | Gentry Leesa | Buy | 128.55K | $0.98 | 125.98K |
| 2026-04-03 | Agah Ramtin | Buy | 621.73K | $0.98 | 609.29K |
| 2026-03-25 | VOLL MARK | Buy | 12.38K | — | — |
| 2026-03-20 | Marton Laurence | Buy | 9.72K | — | — |
| 2026-03-20 | Marton Laurence | Buy | 4.86K | $1.93 | 9.39K |
| 2026-03-20 | Bagai Shaun | Buy | 24.30K | — | — |
| 2026-03-20 | Bagai Shaun | Buy | 12.15K | $1.93 | 23.48K |
| 2026-03-20 | VOLL MARK | Buy | 97.20K | — | — |
| 2026-03-20 | VOLL MARK | Buy | 48.60K | $1.93 | 93.92K |
| 2026-02-04 | VOLL MARK | Other | 0 | — | — |
| 2026-01-21 | Agah Ramtin | Buy | 10.00K | $1.00 | 9.97K |
| 2025-12-31 | Agah Ramtin | Buy | 9.79K | $0.86 | 8.42K |
| 2025-12-30 | Agah Ramtin | Buy | 205 | $0.83 | 169 |
| 2025-12-18 | Bagai Shaun | Buy | 5.00K | $0.90 | 4.51K |
| 2025-12-17 | Bagai Shaun | Buy | 5.00K | $0.85 | 4.26K |
| 2025-12-16 | Agah Ramtin | Buy | 12.00K | $0.85 | 10.20K |
| 2025-12-05 | Agah Ramtin | Buy | 10.00K | $0.96 | 9.60K |
| 2025-11-24 | Agah Ramtin | Buy | 12.00K | $0.80 | 9.60K |
| 2025-11-21 | Agah Ramtin | Buy | 10.00K | $0.80 | 8.00K |
| 2025-10-01 | Marton Laurence | Buy | 47.64K | $1.34 | 63.84K |
| 2025-10-01 | Macfarlane K. Angela | Buy | 47.64K | $1.34 | 63.84K |
| 2025-10-01 | RYAN UNA S | Buy | 47.64K | $1.34 | 63.84K |
| 2025-10-01 | Spiegel Robert J. | Buy | 47.64K | $1.34 | 63.84K |
| 2025-08-25 | Bagai Shaun | Buy | 5.00K | $0.91 | 4.55K |
| 2025-08-22 | Bagai Shaun | Buy | 5.00K | $0.95 | 4.75K |
| 2025-07-01 | Agah Ramtin | Buy | 63.64K | $1.27 | 80.82K |
| 2025-07-01 | Bagai Shaun | Buy | 102.50K | $1.27 | 130.17K |
| 2025-07-01 | Gentry Leesa | Buy | 6.62K | $1.27 | 8.41K |
| 2025-07-01 | Kocak Ron | Buy | 41.60K | $1.27 | 52.83K |
| 2025-06-05 | Agah Ramtin | Buy | 21.00K | $1.40 | 29.40K |
| 2025-05-02 | Marton Laurence | Buy | 20.48K | $0.15 | 3.07K |
| 2025-05-02 | Marton Laurence | Sell | 20.48K | $0.15 | 3.07K |
| 2025-04-22 | Agah Ramtin | Sell | 400.00K | — | — |
| 2025-04-15 | Agah Ramtin | Buy | 15.00K | $0.90 | 13.50K |
| 2025-04-15 | Bagai Shaun | Buy | 7.50K | $0.91 | 6.82K |
| 2025-04-14 | Bagai Shaun | Buy | 409.99K | $0.84 | 346.36K |
| 2025-04-14 | Gentry Leesa | Buy | 26.48K | $0.84 | 22.37K |
| 2025-04-14 | Kocak Ron | Buy | 166.40K | $0.84 | 140.57K |
| 2025-04-14 | Agah Ramtin | Buy | 254.54K | $0.84 | 215.04K |
| 2025-04-11 | Agah Ramtin | Buy | 20.00K | $0.80 | 16.00K |
| 2025-04-10 | Kocak Ron | Buy | 6.50K | $0.79 | 5.13K |
| 2025-04-09 | Kocak Ron | Buy | 6.00K | $0.80 | 4.80K |
| 2025-04-09 | Agah Ramtin | Buy | 30.00K | $0.81 | 24.40K |
| 2025-04-09 | Bagai Shaun | Buy | 10.00K | $0.83 | 8.30K |
| 2025-04-08 | Kocak Ron | Buy | 95 | $0.80 | 76 |
| 2025-04-08 | Marton Laurence | Buy | 12.05K | $0.85 | 10.22K |
| 2025-04-08 | Agah Ramtin | Buy | 26.00K | $0.84 | 21.84K |
| 2025-04-07 | Bagai Shaun | Buy | 10.00K | $0.83 | 8.30K |
| 2024-10-01 | RYAN UNA S | Buy | 25.10K | $1.02 | 25.60K |
| 2024-10-01 | Macfarlane K. Angela | Buy | 25.10K | $1.02 | 25.60K |
| 2024-10-01 | Marton Laurence | Buy | 25.10K | $1.02 | 25.60K |
| 2024-10-01 | Spiegel Robert J. | Buy | 25.10K | $1.02 | 25.60K |
| 2024-03-06 | Gentry Leesa | Buy | 190.00K | $1.69 | 321.10K |
| 2024-02-09 | Kocak Ron | Buy | 15.00K | $1.59 | 23.85K |
| 2024-01-26 | Agah Ramtin | Buy | 40.98K | $1.22 | 50.00K |
| 2024-01-26 | Agah Ramtin | Buy | 40.98K | $1.22 | 50.00K |
| 2024-01-26 | Spiegel Robert J. | Buy | 40.98K | $1.22 | 50.00K |
| 2024-01-26 | Spiegel Robert J. | Buy | 40.98K | $1.22 | 50.00K |
| 2024-01-26 | Bagai Shaun | Buy | 40.98K | $1.22 | 50.00K |
| 2024-01-26 | Bagai Shaun | Buy | 40.98K | $1.22 | 50.00K |
| 2024-01-26 | Marton Laurence | Buy | 8.20K | $1.22 | 10.00K |
| 2024-01-26 | Marton Laurence | Buy | 8.20K | $1.22 | 10.00K |
| 2024-01-26 | Macfarlane K. Angela | Buy | 40.98K | $1.22 | 50.00K |
| 2024-01-26 | Macfarlane K. Angela | Buy | 40.98K | $1.22 | 50.00K |
| 2024-01-19 | Gentry Leesa | Sell | 60.16K | $1.08 | 64.97K |
| 2024-01-19 | Kocak Ron | Sell | 48.13K | $1.08 | 51.98K |
| 2024-01-19 | Kocak Ron | Sell | 12.25K | $1.08 | 13.23K |
| 2024-01-19 | Nelms Angela | Buy | 125.13K | $1.08 | 135.14K |
| 2024-01-19 | Nelms Angela | Buy | 33.77K | $1.08 | 36.47K |
| 2024-01-19 | Agah Ramtin | Buy | 125.13K | $1.08 | 135.14K |
| 2024-01-19 | Agah Ramtin | Buy | 28.42K | $1.08 | 30.70K |
| 2024-01-19 | Bagai Shaun | Buy | 250.26K | $1.08 | 270.28K |
| 2024-01-19 | Bagai Shaun | Buy | 66.97K | $1.08 | 72.33K |
| 2023-10-03 | Nelms Angela | Buy | 800 | $1.04 | 836 |
| 2023-10-03 | Nelms Angela | Buy | 300 | $1.05 | 315 |
| 2023-10-01 | Spiegel Robert J. | Buy | 25.10K | $1.33 | 33.38K |
| 2023-10-01 | Marton Laurence | Buy | 25.10K | $1.33 | 33.38K |
| 2023-10-01 | RYAN UNA S | Buy | 25.10K | $1.33 | 33.38K |
| 2023-10-01 | Diamond David | Buy | 25.10K | $1.33 | 33.38K |
| 2023-10-01 | Macfarlane K. Angela | Buy | 25.10K | $1.33 | 33.38K |
| 2023-06-01 | Gentry Leesa | Sell | 62.50K | $2.11 | 131.88K |
| 2023-06-01 | Kocak Ron | Sell | 3.00K | $2.11 | 6.33K |
| 2023-04-25 | Spiegel Robert J. | Buy | 43.03K | $2.74 | 117.89K |
| 2023-04-25 | Spiegel Robert J. | Other | 0 | — | — |
| 2023-03-15 | Kocak Ron | Sell | 15.88K | $3.29 | 52.23K |
| 2023-03-15 | Agah Ramtin | Buy | 65.00K | $3.29 | 213.85K |
| 2023-03-15 | Bagai Shaun | Buy | 130.00K | $3.29 | 427.70K |
| 2023-03-15 | Nelms Angela | Buy | 32.50K | $3.29 | 106.92K |
| 2022-11-03 | Marton Laurence | Buy | 25.44K | $1.70 | 43.24K |
| 2022-11-03 | Marton Laurence | Sell | 25.44K | $1.70 | 43.24K |
| 2022-10-01 | RYAN UNA S | Buy | 25.10K | — | — |
| 2022-10-01 | Marton Laurence | Buy | 25.10K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 29, holders -2 vs prior quarter. Ownership 19.45%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| AIGH CAPITAL MANAGEMENT LLC | 4.41M | 699.24K | +18.87% | 4.32M |
| BLEICHROEDER LP | 1.67M | 0 | 0.00% | 1.63M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.44M | -3.44K | -0.24% | 1.41M |
| GEODE CAPITAL MANAGEMENT, LLC | 424.15K | 42.42K | +11.11% | 415.69K |
| WEALTHSPIRE ADVISORS, LLC | 252.53K | 0 | 0.00% | 247.47K |
| VANGUARD FIDUCIARY TRUST CO | 240.33K | 82.43K | +52.20% | 235.52K |
| CITADEL ADVISORS LLC | 133.60K | -99.09K | -42.58% | 130.93K |
| NORTHERN TRUST CORP | 85.21K | 43.05K | +102.10% | 83.50K |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | 92.36K | 0 | 0.00% | 78.92K |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 74.60K | -24.86K | -25.00% | 73.10K |
| CAPROCK GROUP, LLC | 63.94K | 0 | 0.00% | 62.66K |
| JANE STREET GROUP, LLC | 46.40K | 22.26K | +92.23% | 45.47K |
| KESTRA ADVISORY SERVICES, LLC | 35.52K | 0 | 0.00% | 34.81K |
| TWO SIGMA SECURITIES, LLC | 34.79K | 16.89K | +94.39% | 34.09K |
| XTX TOPCO LTD | 29.98K | -528 | -1.73% | 29.38K |
| CLEAR CREEK FINANCIAL MANAGEMENT, LLC | 29.06K | 29.06K | New | 28.48K |
| STATE STREET CORP | 26.15K | 0 | 0.00% | 25.63K |
| UBS GROUP AG | 20.82K | 17.48K | +523.73% | 20.40K |
| HIGHTOWER ADVISORS, LLC | 20.00K | 0 | 0.00% | 19.60K |
| CETERA INVESTMENT ADVISERS | 19.00K | 1.00K | +5.56% | 18.62K |
| AFFINITY CAPITAL ADVISORS, LLC | 13.28K | 0 | 0.00% | 12.58K |
| CAPTRUST FINANCIAL ADVISORS | 12.31K | 0 | 0.00% | 12.06K |
| RENAISSANCE TECHNOLOGIES LLC | 11.40K | -1.60K | -12.31% | 11.17K |
| MORGAN STANLEY | 7.10K | 0 | 0.00% | 6.96K |
| MIDWAY CAPITAL RESEARCH & MANAGEMENT | 6.30K | 0 | 0.00% | 6.17K |
Earnings and financials
RenovoRx, Inc. (RNXT) trades at $1.43, with a market cap of $64.54M and a trailing P/E of -4.08. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 43000 | 1123000 |
Insights · Dividends · Forecast · Financials · Learn